| n or mean ± SD | Portion or Range |
---|---|---|
Age (years) | 16.4 ± 6.4 | (7.4, 47.7) |
Gender | ||
 Male | 145 | (89%) |
 Female | 18 | (11%) |
BSA (m2) | 1.61 ± 0.39 | (0.77, 2.62) |
Heart Rate (bpm) | 93 ± 21 | (45, 150) |
LVEF (%) | 59 ± 9 | (24, 84) |
LV EDVI (ml/m2) | 70.6 ± 26.9 | (29.4208.6) |
LV ESVI (ml/m2) | 29.6 ± 18.4 | (7.9, 153.7) |
Same Day Hct | ||
 Yes | 146 | (90%) |
 No | 17 | (10%) |
Primary Diagnosis | ||
Congenital | ||
 Arch abnormalities | 5 | (3%) |
 Aortic valve anomalies | 7 | (4%) |
 ASD | 1 | (0.6%) |
 AVSD | 2 | (1.2%) |
 Mitral valve anomalies | 1 | (0.6%) |
 Pulmonary valve anomalies | 5 | (3%) |
 ToF | 4 | (2.5%) |
 Tricuspid anomalies | 1 | (0.6%) |
 VSD | 2 | (1.2%) |
 DILV | 1 | (0.6%) |
 DORV | 1 | (0.6%) |
 CCTGA | 1 | (0.6%) |
 D-TGA | 1 | (0.6%) |
 Other | 2 | (1.2%) |
 Total | 24 | (15%) |
Secondary/Acquired | ||
 Arrhythmia | 2 | (1.2%) |
 Cardiomyopathy | 11 | (7%) |
 Chemotherapy | 6 | (4%) |
 Kawasaki Disease | 1 | (0.6%) |
 Muscular Dystrophy | 86 | (53%) |
 Myocarditis | 9 | (5%) |
 Other acquired | 4 | (3%) |
 Total | 119 | (73%) |
Normal/Control | 18 | (11%) |